Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global qPCR Kits Market by Type (Affinity Purification, Antibody Labeling, Block/Neutralize/Inhibit, Cell Culture, Others), By Application (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global qPCR Kits Market by Type (Affinity Purification, Antibody Labeling, Block/Neutralize/Inhibit, Cell Culture, Others), By Application (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 447927 4200 Medical Devices & Consumables 377 168 Pages 4.6 (35)
                                          

Market Overview:


The global qPCR kits market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for qPCR kits for research and diagnostic applications. Additionally, the growing prevalence of diseases and rising investments in life sciences are also contributing to the growth of this market. On the basis of type, the global qPCR kits market is segmented into affinity purification, antibody labeling, block/neutralize/inhibit, cell culture and others. The block/neutralize/inhibit segment is expected to grow at a CAGR of 11% during the forecast period from 2018 to 2030. This growth can be attributed to increasing demand for these products for research applications. On the basis of application, hospitals & diagnostic laboratories accounted for majority share in 2017 and is projected to maintain its dominance duringthe forecast period from 2018to2030 owingtoits widespread use across various clinical applications such as diagnostics and personalized medicine etc.


Global qPCR Kits Industry Outlook


Product Definition:


Quantitative PCR (qPCR) is a technique used to amplify and detect specific sequences of DNA. The technique can be used to determine the amount of a target sequence in a sample. qPCR kits are pre-packaged, standardized sets of reagents that include primers, probes, and enzymes necessary for performing qPCR. Kits typically contain enough reagents for multiple reactions, making them convenient for use in research or clinical settings. qPCR kits allow users to achieve consistent results from experiment to experiment and enable the detection of very low levels of DNA targets.


Affinity Purification:


The affinity purification process is used to remove endotoxins from the amino acids. The end products of this process are called as high-affinity or pure-affinity proteins. This method is widely used for protein purification and it's a key step in the production of monoclonal antibodies, insulin, and many other therapeutics drugs.


Antibody Labeling:


Antibody labeling is a technique used for the purpose of improving the specificity and sensitivity of an assay. It involves the incorporation of an antibody molecule in place of molecular entities, such as probes or enzymes. The most common application includes ELISA (enzyme-linked immunosorbent assay).


The major advantage associated with this technique is that it allows specific detection and quantification even at low sample volumes.


Application Insights:


Based on application, the global qPCR kits market is segmented into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, research institutes, and others. Hospitals & diagnostic laboratories held the largest share in 2017 owing to an increase in demand for rapid testing solutions for various clinical applications. This segment is also anticipated to grow at a lucrative rate during the forecast period.


Pharmaceutical & biotechnology companies are expected to witness significant growth during the forecast period due to an increase in R&D activities related to new drug development as well as genetic analysis of target genes/molecules using gene-specific probes for their expression studies. Moreover, growing adoption of these products by major players such as Merck Millipore Corporation; Roche Molecular Systems; Thermo Fisher Scientific Inc.; and Life Technologies Corporation will further boost industry growth over the coming years.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of a large number of qPCR manufacturers and suppliers, availability of advanced products, higher adoption rate by researchers for research-based applications, and high healthcare expenditure in this region. The Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing government funding for basic research activities as well as rising demand from clinical researchers for rapid diagnostic solutions. Moreover, an increase in outsourcing opportunities due to economic benefits offered by countries such as China & India are anticipated to drive regional growth over the forecast period.


Growth Factors:


  • Increasing demand for personalized medicine
  • Technological advancements in qPCR kits
  • Rising prevalence of target diseases
  • Growing number of research institutes and universities
  • Increasing public-private investments

Scope Of The Report

Report Attributes

Report Details

Report Title

qPCR Kits Market Research Report

By Type

Affinity Purification, Antibody Labeling, Block/Neutralize/Inhibit, Cell Culture, Others

By Application

Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others

By Companies

Abcam, Agilent Technologies, BioChain, Bio-Rad, BioVision, Cell Signaling Technology, Enzo Life Sciences, Inc., highQu GmbH, Immundiagnostik AG, Leading Biology, MyBioSource.com, PCR Biosystems, Precision Biosystems, Promega, QIAGEN, Roche, ScienCell Research Laboratories, Thermo Fisher Scientific

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

168

Number of Tables & Figures

118

Customization Available

Yes, the report can be customized as per your need.


Global qPCR Kits Market Report Segments:

The global qPCR Kits market is segmented on the basis of:

Types

Affinity Purification, Antibody Labeling, Block/Neutralize/Inhibit, Cell Culture, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abcam
  2. Agilent Technologies
  3. BioChain
  4. Bio-Rad
  5. BioVision
  6. Cell Signaling Technology
  7. Enzo Life Sciences, Inc.
  8. highQu GmbH
  9. Immundiagnostik AG
  10. Leading Biology
  11. MyBioSource.com
  12. PCR Biosystems
  13. Precision Biosystems
  14. Promega
  15. QIAGEN
  16. Roche
  17. ScienCell Research Laboratories
  18. Thermo Fisher Scientific

Global qPCR Kits Market Overview


Highlights of The qPCR Kits Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Affinity Purification
    2. Antibody Labeling
    3. Block/Neutralize/Inhibit
    4. Cell Culture
    5. Others
  1. By Application:

    1. Hospitals & Diagnostic Laboratories
    2. Pharmaceutical & Biotechnology
    3. Research Institutes
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the qPCR Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global qPCR Kits Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


qPCR Kits are a type of laboratory equipment that allow scientists to perform quantitative PCR (qPCR) on a wide range of samples. qPCR is an extremely versatile technique that can be used to detect the presence or absence of specific genes, sequences, or markers in a sample. qPCR Kits typically include all the necessary reagents and instructions needed for performing the assay, making them ideal for use in research laboratories.

Some of the major players in the qpcr kits market are Abcam, Agilent Technologies, BioChain, Bio-Rad, BioVision, Cell Signaling Technology, Enzo Life Sciences, Inc., highQu GmbH, Immundiagnostik AG, Leading Biology, MyBioSource.com, PCR Biosystems, Precision Biosystems, Promega, QIAGEN, Roche, ScienCell Research Laboratories, Thermo Fisher Scientific.

The qpcr kits market is expected to grow at a compound annual growth rate of 10.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 qPCR Kits Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 qPCR Kits Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 qPCR Kits Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the qPCR Kits Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global qPCR Kits Market Size & Forecast, 2020-2028       4.5.1 qPCR Kits Market Size and Y-o-Y Growth       4.5.2 qPCR Kits Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Affinity Purification
      5.2.2 Antibody Labeling
      5.2.3 Block/Neutralize/Inhibit
      5.2.4 Cell Culture
      5.2.5 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospitals & Diagnostic Laboratories
      6.2.2 Pharmaceutical & Biotechnology
      6.2.3 Research Institutes
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global qPCR Kits Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 qPCR Kits Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Affinity Purification
      9.6.2 Antibody Labeling
      9.6.3 Block/Neutralize/Inhibit
      9.6.4 Cell Culture
      9.6.5 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospitals & Diagnostic Laboratories
      9.10.2 Pharmaceutical & Biotechnology
      9.10.3 Research Institutes
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Affinity Purification
      10.6.2 Antibody Labeling
      10.6.3 Block/Neutralize/Inhibit
      10.6.4 Cell Culture
      10.6.5 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospitals & Diagnostic Laboratories
      10.10.2 Pharmaceutical & Biotechnology
      10.10.3 Research Institutes
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Affinity Purification
      11.6.2 Antibody Labeling
      11.6.3 Block/Neutralize/Inhibit
      11.6.4 Cell Culture
      11.6.5 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospitals & Diagnostic Laboratories
      11.10.2 Pharmaceutical & Biotechnology
      11.10.3 Research Institutes
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Affinity Purification
      12.6.2 Antibody Labeling
      12.6.3 Block/Neutralize/Inhibit
      12.6.4 Cell Culture
      12.6.5 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospitals & Diagnostic Laboratories
      12.10.2 Pharmaceutical & Biotechnology
      12.10.3 Research Institutes
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Affinity Purification
      13.6.2 Antibody Labeling
      13.6.3 Block/Neutralize/Inhibit
      13.6.4 Cell Culture
      13.6.5 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospitals & Diagnostic Laboratories
      13.10.2 Pharmaceutical & Biotechnology
      13.10.3 Research Institutes
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 qPCR Kits Market: Competitive Dashboard
   14.2 Global qPCR Kits Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Abcam
      14.3.2 Agilent Technologies
      14.3.3 BioChain
      14.3.4 Bio-Rad
      14.3.5 BioVision
      14.3.6 Cell Signaling Technology
      14.3.7 Enzo Life Sciences, Inc.
      14.3.8 highQu GmbH
      14.3.9 Immundiagnostik AG
      14.3.10 Leading Biology
      14.3.11 MyBioSource.com
      14.3.12 PCR Biosystems
      14.3.13 Precision Biosystems
      14.3.14 Promega
      14.3.15 QIAGEN
      14.3.16 Roche
      14.3.17 ScienCell Research Laboratories
      14.3.18 Thermo Fisher Scientific

Our Trusted Clients

Contact Us